expected weight loss semaglutide Ozempic® (semaglutide) and Mounjaro™ (tirzepatide), a major breakthrough for the treatment of obesity Semaglutide for Weight Loss: How

February 20, 2025: The Food and Drug Administration updates the Ozempic label

Patients typically see: 4% body weight reduction after two months 6% reduction after three months 8% reduction after four months Long-term Results (Beyond Week 20) Extended treatment shows impressive outcomes: Average weight loss of 15% by month 17 Sustained results through continued treatment Improved metabolic health markers You should take a missed dose within five days for the best results

But a closer look at their origins reveals a far less conventional story than most modern drugs

Dosing of Ozempic and Wegovy Below is an example of the dosing schedule for Wegovy and Ozempic: Wegovy: Month 1 (weeks 1-4) 0.25mg each week Month 2 (weeks 5-8) 0.5mg each week Month 3 (weeks 9-12) 1mg each week Month 4 (weeks 13-16) 1.7mg each week Month 5 (week 17 and onward) 2.4mg each week Ozempic: Month 1 (weeks 1-4) 0.25mg each week Month 2 (weeks 5-8) 0.5mg each week Month 3 (weeks 9-12) 0.5mg each week Month 4 (weeks 13-16) 0.5mg each week Month 5 (week 17 and onward) 0.5mg each week If additional blood sugar control is needed, Ozempic 1mg or 2mg can be used under the supervision of a healthcare professional

Cagrilintide Dosage Chart Cagrilintide is dosed at 600 mcg4.5 mg weekly by subcutaneous injection in educational protocols, starting low and titrating upward